Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Valeria Quaranta

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5019450534. Sources: OpenAlex.

Their work

Papers
9 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2016: 3 papers · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 3 papers

Papers 9

  1. Macrophage-fibroblast JAK/STAT dependent crosstalk promotes liver metastatic outgrowth in pancreatic cancer. Co-author DOI 10.1038/s41467-024-47949-3↗
  2. Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s43018-024-00731-2↗
  3. Author Correction: Efferocytosis reprograms the tumor microenvironment to promote pancreatic cancer liver metastasis. Co-author DOI 10.1038/s43018-024-00751-y↗
  4. Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Co-author DOI 10.1136/gutjnl-2021-325272↗
  5. Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-17-3876↗
  6. Macrophages suppress anti-tumour immunity in metastatic pancreatic cancer Co-author DOI 10.17638/03032847↗
  7. Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. First author DOI 10.1038/ncb3340↗
  8. Corrigendum: Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis. First author DOI 10.1038/ncb3377↗
  9. Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors. Co-author DOI 10.1158/0008-5472.can-16-1201↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael C. Schmid · 8 shared papers, 2016–2024 · strength 0.85
  2. Ainhoa Mielgo · 8 shared papers, 2016–2024 · strength 0.85
  3. Daniel H. Palmer · 7 shared papers, 2016–2024 · strength 0.81
  4. Meirion Raymant · 5 shared papers, 2018–2024 · strength 0.71
  5. Yuliana Astuti · 4 shared papers, 2022–2024 · strength 0.64
  6. Paula Ghaneh · 4 shared papers, 2022–2024 · strength 0.64
  7. Gaia Bellomo · 4 shared papers, 2022–2024 · strength 0.64
  8. Jennifer P. Morton · 4 shared papers, 2022–2024 · strength 0.64
  9. Christopher Michael Halloran · 4 shared papers, 2022–2024 · strength 0.64
  10. Robert Peter Jones · 3 shared papers, 2022–2024 · strength 0.47
  11. Carolyn Rainer · 5 shared papers, 2016–2022 · strength 0.34
  12. Sebastian Rune Nielsen · 4 shared papers, 2016–2018 · strength 0.21
  13. Dannielle D. Engle · 4 shared papers, 2016–2018 · strength 0.21
  14. David Arthur Tuveson · 4 shared papers, 2016–2018 · strength 0.21
  15. Mark A. Glenn · 1 shared paper, 2024 · strength 0.18
  16. Lucy Ireland · 3 shared papers, 2016 · strength 0.14
  17. Pedro Antonio Pérez-Mancera · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.